LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 46 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q1 2022. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $118,000 | -19.2% | 36,993 | +8.3% | 0.00% | – |
| Q1 2022 | $146,000 | -63.1% | 34,146 | -59.9% | 0.00% | – |
| Q4 2021 | $396,000 | +238.5% | 85,164 | +189.7% | 0.00% | – |
| Q3 2021 | $117,000 | -62.5% | 29,400 | -59.7% | 0.00% | – |
| Q2 2021 | $312,000 | -9.0% | 73,022 | -9.8% | 0.00% | – |
| Q1 2021 | $343,000 | -48.0% | 80,997 | -52.4% | 0.00% | – |
| Q4 2020 | $660,000 | +33.6% | 170,120 | +38.9% | 0.00% | – |
| Q3 2020 | $494,000 | +12.8% | 122,501 | +19.2% | 0.00% | – |
| Q2 2020 | $438,000 | 0.0% | 102,791 | -1.5% | 0.00% | – |
| Q1 2020 | $438,000 | -32.3% | 104,338 | -36.6% | 0.00% | – |
| Q4 2019 | $647,000 | -46.3% | 164,675 | +20.3% | 0.00% | – |
| Q3 2019 | $1,204,000 | -83.6% | 136,885 | -82.7% | 0.00% | – |
| Q2 2019 | $7,326,000 | +1135.4% | 792,000 | +758.1% | 0.00% | – |
| Q1 2019 | $593,000 | -1.0% | 92,299 | +45.2% | 0.00% | – |
| Q4 2018 | $599,000 | -81.5% | 63,550 | -60.4% | 0.00% | -100.0% |
| Q3 2018 | $3,231,000 | +47.5% | 160,500 | +113.6% | 0.00% | – |
| Q2 2018 | $2,191,000 | -65.7% | 75,127 | -65.0% | 0.00% | -100.0% |
| Q1 2018 | $6,385,000 | -18.4% | 214,422 | -11.8% | 0.00% | 0.0% |
| Q4 2017 | $7,823,000 | -79.1% | 243,100 | -77.4% | 0.00% | -86.7% |
| Q3 2017 | $37,359,000 | +618.7% | 1,074,139 | +515.1% | 0.02% | +650.0% |
| Q2 2017 | $5,198,000 | +37.1% | 174,626 | +37.5% | 0.00% | 0.0% |
| Q1 2017 | $3,791,000 | +68.1% | 127,000 | -1.3% | 0.00% | +100.0% |
| Q4 2016 | $2,255,000 | -10.4% | 128,646 | +21.5% | 0.00% | 0.0% |
| Q3 2016 | $2,518,000 | +49.3% | 105,840 | +0.4% | 0.00% | – |
| Q2 2016 | $1,687,000 | -6.6% | 105,423 | +22.0% | 0.00% | -100.0% |
| Q1 2016 | $1,806,000 | -6.9% | 86,400 | +20.2% | 0.00% | – |
| Q4 2015 | $1,940,000 | -45.3% | 71,859 | -43.7% | 0.00% | -100.0% |
| Q3 2015 | $3,547,000 | +22.0% | 127,644 | +7.6% | 0.00% | +100.0% |
| Q2 2015 | $2,907,000 | +74.4% | 118,600 | +30.3% | 0.00% | 0.0% |
| Q1 2015 | $1,667,000 | – | 91,053 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,914,970 | $81,007,000 | 29.87% |
| RTW INVESTMENTS, LP | 1,080,331 | $30,022,000 | 9.33% |
| Avoro Capital Advisors LLC | 804,299 | $22,351,000 | 5.81% |
| ACUTA CAPITAL PARTNERS, LLC | 122,222 | $3,397,000 | 1.97% |
| Broadfin Capital, LLC | 1,095,373 | $30,440,000 | 1.69% |
| Belmont Global Advisors, Inc. | 35,000 | $973,000 | 1.65% |
| P.A.W. CAPITAL CORP | 48,000 | $1,334,000 | 1.53% |
| Perceptive Advisors | 1,309,030 | $36,378,000 | 1.45% |
| Iguana Healthcare Management, LLC | 125,000 | $3,474,000 | 1.37% |
| EAM Investors, LLC | 97,350 | $2,705,000 | 0.43% |